Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer.

Dorta-Estremera S, Hegde VL, Slay RB, Sun R, Yanamandra AV, Nicholas C, Nookala S, Sierra G, Curran MA, Sastry KJ.

J Immunother Cancer. 2019 Sep 18;7(1):252. doi: 10.1186/s40425-019-0728-4.

2.

Discovery of IACS-8803 and IACS-8779, potent agonists of stimulator of interferon genes (STING) with robust systemic antitumor efficacy.

Ager CR, Zhang H, Wei Z, Jones P, Curran MA, Di Francesco ME.

Bioorg Med Chem Lett. 2019 Aug 24:126640. doi: 10.1016/j.bmcl.2019.126640. [Epub ahead of print]

PMID:
31500996
3.

Heteronormativity in the Lives of Lesbian, Gay, Bisexual, and Queer Young People.

Pollitt AM, Mernitz SE, Russell ST, Curran MA, Toomey RB.

J Homosex. 2019 Aug 22:1-23. doi: 10.1080/00918369.2019.1656032. [Epub ahead of print]

PMID:
31437417
4.

Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression.

Hu Q, Ye Y, Chan LC, Li Y, Liang K, Lin A, Egranov SD, Zhang Y, Xia W, Gong J, Pan Y, Chatterjee SS, Yao J, Evans KW, Nguyen TK, Park PK, Liu J, Coarfa C, Donepudi SR, Putluri V, Putluri N, Sreekumar A, Ambati CR, Hawke DH, Marks JR, Gunaratne PH, Caudle AS, Sahin AA, Hortobagyi GN, Meric-Bernstam F, Chen L, Yu D, Hung MC, Curran MA, Han L, Lin C, Yang L.

Nat Immunol. 2019 Jul;20(7):835-851. doi: 10.1038/s41590-019-0400-7. Epub 2019 Jun 3.

PMID:
31160797
5.

EnanDIM - a novel family of L-nucleotide-protected TLR9 agonists for cancer immunotherapy.

Kapp K, Volz B, Curran MA, Oswald D, Wittig B, Schmidt M.

J Immunother Cancer. 2019 Jan 8;7(1):5. doi: 10.1186/s40425-018-0470-3.

6.

New Hope for Therapeutic Cancer Vaccines in the Era of Immune Checkpoint Modulation.

Curran MA, Glisson BS.

Annu Rev Med. 2019 Jan 27;70:409-424. doi: 10.1146/annurev-med-050217-121900. Epub 2018 Oct 31.

PMID:
30379596
7.

Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma.

Zhou L, Husted H, Moore T, Lu M, Deng D, Liu Y, Ramachandran V, Arumugam T, Niehrs C, Wang H, Chiao P, Ling J, Curran MA, Maitra A, Hung MC, Lee JE, Logsdon CD, Hwang RF.

Sci Transl Med. 2018 Oct 24;10(464). pii: eaat3487. doi: 10.1126/scitranslmed.aat3487.

8.

Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy.

Jayaprakash P, Ai M, Liu A, Budhani P, Bartkowiak T, Sheng J, Ager C, Nicholas C, Jaiswal AR, Sun Y, Shah K, Balasubramanyam S, Li N, Wang G, Ning J, Zal A, Zal T, Curran MA.

J Clin Invest. 2018 Nov 1;128(11):5137-5149. doi: 10.1172/JCI96268. Epub 2018 Oct 15.

9.

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma.

Jamieson SM, Tsai P, Kondratyev MK, Budhani P, Liu A, Senzer NN, Chiorean EG, Jalal SI, Nemunaitis JJ, Kee D, Shome A, Wong WW, Li D, Poonawala-Lohani N, Kakadia PM, Knowlton NS, Lynch CR, Hong CR, Lee TW, Grénman RA, Caporiccio L, McKee TD, Zaidi M, Butt S, Macann AM, McIvor NP, Chaplin JM, Hicks KO, Bohlander SK, Wouters BG, Hart CP, Print CG, Wilson WR, Curran MA, Hunter FW.

JCI Insight. 2018 Aug 23;3(16). pii: 122204. doi: 10.1172/jci.insight.122204. eCollection 2018 Aug 23.

10.

Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV+ Oral Cancers.

Dorta-Estremera S, Chin RL, Sierra G, Nicholas C, Yanamandra AV, Nookala SMK, Yang G, Singh S, Curran MA, Sastry KJ.

Cancer Res. 2018 Sep 15;78(18):5327-5339. doi: 10.1158/0008-5472.CAN-18-0892. Epub 2018 Jul 27.

11.

Oregon's Familias en Acción replicates benefits for underserved cancer co-survivors through Un Abrazo Para la Familia.

Marshall CA, Curran MA, Brownmiller G, Solarte A, Armin J, Hamann HA, Crist JD, Niemelä M, Badger TA, Weihs KL.

Psychooncology. 2018 Oct;27(10):2405-2411. doi: 10.1002/pon.4841. Epub 2018 Aug 15.

PMID:
30047167
12.

PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell-Driven Antitumor Immunity.

Buchan SL, Fallatah M, Thirdborough SM, Taraban VY, Rogel A, Thomas LJ, Penfold CA, He LZ, Curran MA, Keler T, Al-Shamkhani A.

Clin Cancer Res. 2018 May 15;24(10):2383-2394. doi: 10.1158/1078-0432.CCR-17-3057. Epub 2018 Mar 7.

13.

Case 31-2017: A 19-Month-Old Girl with Failure to Thrive.

Madhavan VL, Curran MA, Lindgren K.

N Engl J Med. 2018 Feb 15;378(7):686. doi: 10.1056/NEJMc1714806. No abstract available.

PMID:
29443672
14.

Preclinical Data Supporting Antitumor Activity of PD-1 Blockade.

Curran MA.

Cancer J. 2018 Jan/Feb;24(1):2-6. doi: 10.1097/PPO.0000000000000298. Review.

PMID:
29360721
15.

Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27-Dependent Pathway.

Bartkowiak T, Jaiswal AR, Ager CR, Chin R, Chen CH, Budhani P, Ai M, Reilley MJ, Sebastian MM, Hong DS, Curran MA.

Clin Cancer Res. 2018 Mar 1;24(5):1138-1151. doi: 10.1158/1078-0432.CCR-17-1847. Epub 2018 Jan 4.

16.

Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain.

Singh M, Vianden C, Cantwell MJ, Dai Z, Xiao Z, Sharma M, Khong H, Jaiswal AR, Faak F, Hailemichael Y, Janssen LME, Bharadwaj U, Curran MA, Diab A, Bassett RL, Tweardy DJ, Hwu P, Overwijk WW.

Nat Commun. 2017 Nov 13;8(1):1447. doi: 10.1038/s41467-017-01572-7.

17.

Case 31-2017. A 19-Month-Old Girl with Failure to Thrive.

Curran MA, Madhavan VL, Caruso PA, Ebb DH, Williams EA.

N Engl J Med. 2017 Oct 12;377(15):1468-1477. doi: 10.1056/NEJMcpc1706106. No abstract available.

PMID:
29020588
18.

Patterns of interparental conflict, parenting, and children's emotional insecurity: A person-centered approach.

Kopystynska O, Paschall KW, Barnett MA, Curran MA.

J Fam Psychol. 2017 Oct;31(7):922-932. doi: 10.1037/fam0000343. Epub 2017 Aug 10.

PMID:
28795829
19.

Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity.

Ager CR, Reilley MJ, Nicholas C, Bartkowiak T, Jaiswal AR, Curran MA.

Cancer Immunol Res. 2017 Aug;5(8):676-684. doi: 10.1158/2326-6066.CIR-17-0049. Epub 2017 Jul 3.

20.

Atmospheric impacts of the strongest known solar particle storm of 775 AD.

Sukhodolov T, Usoskin I, Rozanov E, Asvestari E, Ball WT, Curran MA, Fischer H, Kovaltsov G, Miyake F, Peter T, Plummer C, Schmutz W, Severi M, Traversi R.

Sci Rep. 2017 Mar 28;7:45257. doi: 10.1038/srep45257.

21.

Antarctic ice sheet discharge driven by atmosphere-ocean feedbacks at the Last Glacial Termination.

Fogwill CJ, Turney CS, Golledge NR, Etheridge DM, Rubino M, Thornton DP, Baker A, Woodward J, Winter K, van Ommen TD, Moy AD, Curran MA, Davies SM, Weber ME, Bird MI, Munksgaard NC, Menviel L, Rootes CM, Ellis B, Millman H, Vohra J, Rivera A, Cooper A.

Sci Rep. 2017 Jan 5;7:39979. doi: 10.1038/srep39979.

22.

Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells.

Tang C, Welsh JW, de Groot P, Massarelli E, Chang JY, Hess KR, Basu S, Curran MA, Cabanillas ME, Subbiah V, Fu S, Tsimberidou AM, Karp D, Gomez DR, Diab A, Komaki R, Heymach JV, Sharma P, Naing A, Hong DS.

Clin Cancer Res. 2017 Mar 15;23(6):1388-1396. doi: 10.1158/1078-0432.CCR-16-1432. Epub 2016 Sep 20.

23.

Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.

Chouaib S, Noman MZ, Kosmatopoulos K, Curran MA.

Oncogene. 2017 Jan 26;36(4):439-445. doi: 10.1038/onc.2016.225. Epub 2016 Jun 27. Review.

24.

Intimacy Behaviors and Relationship Satisfaction for Cohabitors: Intimate Sacrifices Are Not Always Beneficial.

Young VJ, Curran MA.

J Psychol. 2016 Aug 17;150(6):779-92. doi: 10.1080/00223980.2016.1187110. Epub 2016 Jun 7.

PMID:
27269507
25.

Child Poverty: The United Kingdom Experience.

Mansour JG, Curran MA.

Acad Pediatr. 2016 Apr;16(3 Suppl):S76-82. doi: 10.1016/j.acap.2016.01.012.

PMID:
27044706
26.

Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.

Gabrusiewicz K, Rodriguez B, Wei J, Hashimoto Y, Healy LM, Maiti SN, Thomas G, Zhou S, Wang Q, Elakkad A, Liebelt BD, Yaghi NK, Ezhilarasan R, Huang N, Weinberg JS, Prabhu SS, Rao G, Sawaya R, Langford LA, Bruner JM, Fuller GN, Bar-Or A, Li W, Colen RR, Curran MA, Bhat KP, Antel JP, Cooper LJ, Sulman EP, Heimberger AB.

JCI Insight. 2016;1(2). pii: 85841. doi: 10.1172/jci.insight.85841. Epub 2016 Feb 25.

27.

Gender, Emotion Work, and Relationship Quality: A Daily Diary Study.

Curran MA, McDaniel BT, Pollitt AM, Totenhagen CJ.

Sex Roles. 2015 Aug;73(3-4):157-173. Epub 2015 Jun 9.

28.

Development of an International Elective in an Emergency Medicine Residency.

Hayden SR, Valderrama CM, Xu M, Curran MA, Mazondo R, Soliman MA.

J Emerg Med. 2016 Jan;50(1):153-8. doi: 10.1016/j.jemermed.2015.06.015. Epub 2015 Oct 9.

PMID:
26443645
29.

Editorial: Advances in Combination Tumor Immunotherapy.

Curran MA, Fox BA, Redmond WL.

Front Oncol. 2015 Sep 22;5:198. doi: 10.3389/fonc.2015.00198. eCollection 2015. No abstract available.

30.

Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccine.

Bartkowiak T, Singh S, Yang G, Galvan G, Haria D, Ai M, Allison JP, Sastry KJ, Curran MA.

Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):E5290-9. doi: 10.1073/pnas.1514418112. Epub 2015 Sep 8.

31.

4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity.

Bartkowiak T, Curran MA.

Front Oncol. 2015 Jun 8;5:117. doi: 10.3389/fonc.2015.00117. eCollection 2015. Review.

32.

Immune checkpoint combinations from mouse to man.

Ai M, Curran MA.

Cancer Immunol Immunother. 2015 Jul;64(7):885-92. doi: 10.1007/s00262-014-1650-8. Epub 2015 Jan 3. Review.

PMID:
25555570
33.

Perceived barriers and facilitators for an academic career in geriatrics: medical students' perspectives.

Curran MA, Black M, Depp CA, Iglewicz A, Reichstadt J, Palinkas L, Jeste DV.

Acad Psychiatry. 2015 Jun;39(3):253-8. doi: 10.1007/s40596-014-0208-6. Epub 2014 Jul 31.

34.

Association of learning styles with research self-efficacy: study of short-term research training program for medical students.

Dumbauld J, Black M, Depp CA, Daly R, Curran MA, Winegarden B, Jeste DV.

Clin Transl Sci. 2014 Dec;7(6):489-92. doi: 10.1111/cts.12197. Epub 2014 Jul 31.

35.

Antarctic-wide array of high-resolution ice core records reveals pervasive lead pollution began in 1889 and persists today.

McConnell JR, Maselli OJ, Sigl M, Vallelonga P, Neumann T, Anschütz H, Bales RC, Curran MA, Das SB, Edwards R, Kipfstuhl S, Layman L, Thomas ER.

Sci Rep. 2014 Jul 28;4:5848. doi: 10.1038/srep05848.

36.

Un Abrazo Para La Familia: an evidenced-based rehabilitation approach in providing cancer education to low-SES Hispanic co-survivors.

Marshall CA, Curran MA, Koerner SS, Kroll T, Hickman AC, García F.

J Cancer Educ. 2014 Dec;29(4):626-33. doi: 10.1007/s13187-013-0593-7.

37.

Evaluating the environmental impacts of a nano-enhanced field emission display using life cycle assessment: a screening-level study.

Upadhyayula VK, Meyer DE, Curran MA, Gonzalez MA.

Environ Sci Technol. 2014 Jan 21;48(2):1194-205. doi: 10.1021/es4034638. Epub 2014 Jan 7.

PMID:
24328392
38.
39.

Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin.

Curran MA, Geiger TL, Montalvo W, Kim M, Reiner SL, Al-Shamkhani A, Sun JC, Allison JP.

J Exp Med. 2013 Apr 8;210(4):743-55. doi: 10.1084/jem.20121190. Epub 2013 Apr 1.

40.

Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer model.

Mineharu Y, Muhammad AK, Yagiz K, Candolfi M, Kroeger KM, Xiong W, Puntel M, Liu C, Levy E, Lugo C, Kocharian A, Allison JP, Curran MA, Lowenstein PR, Castro MG.

Neurotherapeutics. 2012 Oct;9(4):827-43. doi: 10.1007/s13311-012-0144-7.

41.

Daily hassles and uplifts: a diary study on understanding relationship quality.

Totenhagen CJ, Serido J, Curran MA, Butler EA.

J Fam Psychol. 2012 Oct;26(5):719-28. doi: 10.1037/a0029628. Epub 2012 Aug 20.

PMID:
22906123
42.

Repertoire enhancement with adoptively transferred female lymphocytes controls the growth of pre-implanted murine prostate cancer.

Jenq RR, Curran MA, Goldberg GL, Liu C, Allison JP, van den Brink MR.

PLoS One. 2012;7(4):e35222. doi: 10.1371/journal.pone.0035222. Epub 2012 Apr 6.

43.

Response to "Ipilimumab (Yervoy) and the TGN1412 catastrophe".

Curran MA, Callahan MK, Subudhi SK, Allison JP.

Immunobiology. 2012 Jun;217(6):590-2. doi: 10.1016/j.imbio.2011.11.001. Epub 2011 Nov 17. No abstract available.

PMID:
22459268
44.

Assessment of a cohort of primarily pediatric patients with a presumptive diagnosis of type 1 von Willebrand disease with a novel high shear rate, non-citrated blood flow device.

Grabowski EF, Curran MA, Van Cott EM.

Thromb Res. 2012 Apr;129(4):e18-24. doi: 10.1016/j.thromres.2011.12.016. Epub 2012 Jan 20.

PMID:
22265674
45.

Physical attractiveness, issue agreement, and assimilation effects in candidate appraisal.

Schubert JN, Curran MA, Strungaru C.

Politics Life Sci. 2011 Spring;30(1):33-49. doi: 10.2990/30_1_33.

PMID:
22204678
46.

Un Abrazo Para La Familia: providing low-income Hispanics with education and skills in coping with breast cancer and caregiving.

Marshall CA, Badger TA, Curran MA, Koerner SS, Larkey LK, Weihs KL, Verdugo L, García FA.

Psychooncology. 2013 Feb;22(2):470-4. doi: 10.1002/pon.2108. Epub 2011 Dec 2.

47.

"Like a Mexican wedding": psychosocial intervention needs of predominately Hispanic low-income female co-survivors of cancer.

Marshall CA, Weihs KL, Larkey LK, Badger TA, Koerner SS, Curran MA, Pedroza R, García FA.

J Fam Nurs. 2011 Aug;17(3):380-402. doi: 10.1177/1074840711416119.

48.

Considerations of culture and social class for families facing cancer: the need for a new model for health promotion and psychosocial intervention.

Marshall CA, Larkey LK, Curran MA, Weihs KL, Badger TA, Armin J, García F.

Fam Syst Health. 2011 Jun;29(2):81-94. doi: 10.1037/a0023975.

49.

Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production.

Curran MA, Kim M, Montalvo W, Al-Shamkhani A, Allison JP.

PLoS One. 2011 Apr 29;6(4):e19499. doi: 10.1371/journal.pone.0019499.

50.

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors.

Curran MA, Montalvo W, Yagita H, Allison JP.

Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4275-80. doi: 10.1073/pnas.0915174107. Epub 2010 Feb 16.

Supplemental Content

Loading ...
Support Center